Small Molecule CROs in Asia-Pacific
25 published
25 published CROs match Small Molecule in Asia-Pacific.
Locations in this set include United States, China, India, United Kingdom, Australia, and Germany.
Capabilities that show up most often in this set: Regulatory Affairs, Bioanalysis, Biomarker Assays, Phase IV / Post-Marketing, and Data Management & eClinical.
Matching companies
Sparge Chem Pvt. Ltd.Pune-based provider of custom synthesis, medicinal chemistry, process development, and CRAMS/CDMO services for drug discovery and API intermediates. Offers FTE and fee-for-service engagement models with a 24-hour feasibility response.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
TFS HealthScienceGlobal mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.
TigermedLeading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /modalities/small-molecule/apac.md